Enhancement of angiogenic effect of co-transfection human NGF and VEGF genes in rat bone marrow mesenchymal stem cells

Gene

Volumn 485, Issue 2, 2011, Pages 167-171

  Fan, Bo Sheng ^a   Lou, Ji Yu ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells (BMSCs); Human nerve growth factor; Human vascular endothelial growth factor; Transgene expression

Indexed keywords

COMPLEMENTARY DNA; RECOMBINANT NERVE GROWTH FACTOR; VASCULOTROPIN 165;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BIOASSAY; BIOLOGICAL ACTIVITY; BONE MARROW CELL; CHICK CHORIOALLANTOIC MEMBRANE ASSAY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; MESENCHYME CELL; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CLONING, MOLECULAR; GENE THERAPY; HUMANS; MESENCHYMAL STEM CELLS; NERVE GROWTH FACTOR; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 80052034804     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.06.027     Document Type: Article

References (33)

1. Bacigalupo A. Mesenchymal stem cells and haematopoietic stem cell transplantation. Best Pract. Res. Clin. Haematol. 2004, 17:387-399.
2. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
3. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9:641-650.
4. Conner J.M., Fass-Holmes B., Varon S. Changes in nerve growth factor immunoreactivity following entorhinal cortex lesions: possible molecular mechanism regulating cholinergic sprouting. J. Comp. Neurol. 1994, 345:409-418.
5. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. 2000, 28:875-884.
6. Fan B.S., Lou J.Y. Recombinant expression of human nerve growth factor beta in rabbit bone marrow mesenchymal stem cells. Mol. Biol. Rep. 2010, 37:4083-4090.
7. Fiore M., Chaldakov G.N., Aloe L. Nerve growth factor as a signaling molecule for nerve cells and also for the neuroendocrine-immune systems. Rev. Neurosci. 2009, 20:133-145.
8. Fischer W. Nerve growth factor reverses spatial memory impairments in aged rats. Neurochem. Int. 1994, 25:47-52.
9. Fischer W., Wictorin K., Bjorklund A., Williams L.R., Varon S., Gage F.H. Melioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 1987, 329:65-68.
10. Frade J.M., Barde Y.A. Nerve growth factor: two receptors, multiple functions. Bioessays 1998, 20:137-145.
11. Haynesworth S.E., Baber M.A., Caplan A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J. Cell. Physiol. 1996, 166:585-592.
12. Issa R., Krupinski J., Bujny T., Kumar S., Kaluza J., Kumar P. Vascular endothelial growth factor and its receptor, KDR, inhumanbrain tissue after ischemic stroke. Lab. Invest. 1999, 79:417-425.
13. Jakubowska-Dogru E., Gumusbas U. Chronic intracerebroventricular NGF administration improves working memory in young adult memory deficient rats. Neurosci. Lett. 2005, 382:45-50.
14. Kawamoto K., Matsuda H. Nerve growth factor and wound healing. Prog. Brain Res. 2004, 146:369-384.
15. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 2003, 31:890-896.
16. Lennmyr F., Terént A., Syven A.C., Barbany G. Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat. Acta Anaesthesiol. Scand. 2005, 49:488-493.
17. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., Gerson S.L. Phenotypic and functional comparison of cultures of marrowderived mesenchymal stem cells (MSCs) and stromal cells. J. Cell. Physiol. 1998, 176:57-66.
18. Mammoto T., Seerattan R.A., Paulson K.D., Leonard C.A., Bray R.C., Salo P.T. Nerve growth factor improves ligament healing. J. Orthop. Res. 2008, 26:957-964.
19. Markowska A.L., Koliatsos V.E., Breckler S.J., Price D.L., Olton D.S. Human nerve growth factor improves spatial memory in aged but not in young rats. J. Neurosci. 1994, 14:4815-4824.
20. Mayhan W.G. VEGF increases permeability of the blood-brain barrier via anitric oxide synthase/cGMP-dependent pathway. Am. J. Physiol. 1999, 276:C1148-C1153.
21. McFarlin K., Gao X., Liu Y.B., Dulchavsky D.S., Kwon D., Arbab A.S., Bansal M., Li Y., Chopp M., Dulchavsky S.A., Gautam S.C. Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen. 2006, 14:471-478.
22. Minguell J.J., Erices A., Conget P. Mesenchymal stem cells. Exp. Biol. Med. 2001, 226:507-520.
23. Missale C., Spano P. Nerve growth factor in pituitary development and pituitary tumors. Front. Neuroendocrinol. 1998, 19:128-150.
24. Muangman P., Muffley L.A., Anthony J.P., Spenny M.L., Underwood R.A., Olerud J.E., Gibran N.S. Nerve growth factor accelerates wound healing in diabetic mice. Wound Repair Regen. 2004, 12:44-52.
25. Pearce V. Stem cells and neuroprotection: understanding the players. Int. J. Mol. Sci. 2010, 11:3288-3297.
26. Pizzo D.P., Thal L.J. Intraparenchymal nerve growth factor improves behavioral deficits while minimizing the adverse effects of intracerebroventricular delivery. Neuroscience 2004, 24:743-755.
27. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
28. Rasulov M.F., Vasilchenkov A.V., Onishchenko N.A., Krasheninnikov M.E., Kravchenko V.I., Gorshenin T.L., Pidtsan R.E., Potapov I.V. First experience of the use bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bull. Exp. Biol. Med. 2005, 139:141-144.
29. Rogers B.C. Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease. Neurotoxicology 1996, 17:865-870.
30. Schoch H.J., Fischer S., Marti H.H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002, 125:2549-2557.
31. Scott S.A., Crutcher K.A. Nerve growth factor and Alzheimer's disease. Rev. Neurosci. 1994, 5:179-211.
32. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
33. Yan Y., Xu W., Qian H., Zhu W., Mao F., Zhang X. Tumstatin45-132-TNFalpha suppresses tumour growth through anti-angiogenic effects and cytotoxicity. Biotechnol. Biochem. 2010, 56:119-127.